BCL2 and neoplasm: Nevertheless, the combination of Bcl‐2 inhibition by ABT263 and Bim upregulation by BGJ398 triggers substantial caspase activation in the tumour, which likely contributes to the enhanced cell death following treatment with BGJ398 +  ABT263.